Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth J Phillips

Showing results (21-30 of 303) with videos related to

Pageof 31
Sort By:
The Journal of Clinical Investigation|May 22, 2018
Active suppression rather than ignorance: tolerance to abacavir-induced HLA-B*57:01 peptide repertoire alterationElizabeth J Phillips, Simon A Mallal
AIDS (London, England)|January 8, 2013
HLA-B*5701 and flucloxacillin associated drug-induced liver diseaseElizabeth J Phillips, Simon A Mallal
The Journal of Allergy and Clinical Immunology. in Practice|August 12, 2020
Positioning Drug Allergy Delabeling as a Critical Tool for Precision Medicine, Quality Improvement, and Public HealthKimberly G Blumenthal, Elizabeth J Phillips
JAMA Dermatology|January 11, 2023
Drug Reaction With Eosinophilia and Systemic SymptomsMatthew S Krantz, Elizabeth J Phillips
The New England Journal of Medicine|February 10, 2021
Maintaining Safety with SARS-CoV-2 Vaccines. ReplyMariana C Castells, Elizabeth J Phillips
Current Opinion in Infectious Diseases|January 15, 2008
Pharmacogenetics and the potential for the individualization of antiretroviral therapyElizabeth J Phillips, Simon A Mallal
Current Opinion in Molecular Therapeutics|May 30, 2009
HLA and drug-induced toxicityElizabeth J Phillips, Simon A Mallal
The Lancet. Infectious Diseases|March 10, 2022
COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USAMatthew S Krantz, Elizabeth J Phillips
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 21, 2022
Where to place etanercept and combination treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis?Eric M Mukherjee, Elizabeth J Phillips
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|January 9, 2004
Challenges of adherence management in human immunodeficiency virus pharmacotherapyLaura Y Park-Wyllie, Elizabeth J Phillips
Pageof 31

Showing results (21-30 of 303) with videos related to

Sort By:
Pageof 31
The Journal of Clinical Investigation|May 22, 2018
Active suppression rather than ignorance: tolerance to abacavir-induced HLA-B*57:01 peptide repertoire alterationElizabeth J Phillips, Simon A Mallal
AIDS (London, England)|January 8, 2013
HLA-B*5701 and flucloxacillin associated drug-induced liver diseaseElizabeth J Phillips, Simon A Mallal
The Journal of Allergy and Clinical Immunology. in Practice|August 12, 2020
Positioning Drug Allergy Delabeling as a Critical Tool for Precision Medicine, Quality Improvement, and Public HealthKimberly G Blumenthal, Elizabeth J Phillips
JAMA Dermatology|January 11, 2023
Drug Reaction With Eosinophilia and Systemic SymptomsMatthew S Krantz, Elizabeth J Phillips
The New England Journal of Medicine|February 10, 2021
Maintaining Safety with SARS-CoV-2 Vaccines. ReplyMariana C Castells, Elizabeth J Phillips
Current Opinion in Infectious Diseases|January 15, 2008
Pharmacogenetics and the potential for the individualization of antiretroviral therapyElizabeth J Phillips, Simon A Mallal
Current Opinion in Molecular Therapeutics|May 30, 2009
HLA and drug-induced toxicityElizabeth J Phillips, Simon A Mallal
The Lancet. Infectious Diseases|March 10, 2022
COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USAMatthew S Krantz, Elizabeth J Phillips
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 21, 2022
Where to place etanercept and combination treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis?Eric M Mukherjee, Elizabeth J Phillips
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|January 9, 2004
Challenges of adherence management in human immunodeficiency virus pharmacotherapyLaura Y Park-Wyllie, Elizabeth J Phillips
Pageof 31